{"id":"https://openalex.org/W1908974948","doi":"https://doi.org/10.1093/nar/gkv857","title":"In silicoandin vitroevaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization","display_name":"In silicoandin vitroevaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-03","ids":{"openalex":"https://openalex.org/W1908974948","doi":"https://doi.org/10.1093/nar/gkv857","mag":"1908974948","pmid":"https://pubmed.ncbi.nlm.nih.gov/26338776","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4605310"},"language":"en","primary_location":{"id":"doi:10.1093/nar/gkv857","doi":"https://doi.org/10.1093/nar/gkv857","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nar/gkv857","pdf_url":null,"source":{"id":"https://openalex.org/S134668137","display_name":"Nucleic Acids Research","issn_l":"0305-1048","issn":["0305-1048","1362-4954","1362-4962"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1908974948"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/nar/gkv857","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026067835","display_name":"Piotr J. Kamola","orcid":"https://orcid.org/0000-0002-7870-605X","observed_orcids":["https://orcid.org/0000-0002-7870-605X"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I348769827","display_name":"Public Health England","ror":"https://ror.org/00vbvha87","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I348769827"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Piotr J. Kamola","raw_affiliation_strings":["Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK GlaxoSmithKline R&D, Ware SG12 0DP, UK GlaxoSmithKline R&D, Stevenage SG1 2NY, UK Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Science and Innovation Campus OX11 0RQ, UK piotr.j.kamola@gsk.com","1Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK GlaxoSmithKline R&D, Ware SG12 0DP, UK GlaxoSmithKline R&D, Stevenage SG1 2NY, UK Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Science and Innovation Campus OX11 0RQ, UK piotr.j.kamola@gsk.com","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I348769827","https://openalex.org/I47508984"]},{"raw_affiliation_string":"1Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109907588","display_name":"Jeremy Kitson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jeremy\u00a0D.\u00a0A. Kitson","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102070579","display_name":"Gemma Turner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gemma Turner","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057517083","display_name":"Klio Maratou","orcid":"https://orcid.org/0000-0001-6061-2322","observed_orcids":["https://orcid.org/0000-0001-6061-2322"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Klio Maratou","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sofie Eriksson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sofie Eriksson","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024658190","display_name":"Aliza A. Panjwani","orcid":"https://orcid.org/0000-0002-7139-2764","observed_orcids":["https://orcid.org/0000-0002-7139-2764"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Aliza Panjwani","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080733223","display_name":"Linda C. Warnock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Linda C. Warnock","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087338872","display_name":"Ga\u00eblle Douillard\u2010Guilloux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gaelle A. Douillard\u00a0Guilloux","raw_affiliation_strings":["GlaxoSmithKline R&D, Les Ulis 91951, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Les Ulis 91951, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069287119","display_name":"Kitty Moores","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kitty Moores","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000581900","display_name":"Emma L. Koppe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emma L. Koppe","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054882579","display_name":"William E. Wixted","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William E. Wixted","raw_affiliation_strings":["GlaxoSmithKline R&D, Upper Merion 19406, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Upper Merion 19406, US","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033735039","display_name":"Paul A. Wilson","orcid":"https://orcid.org/0000-0003-4151-1846","observed_orcids":["https://orcid.org/0000-0003-4151-1846"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul A. Wilson","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005346296","display_name":"Nigel J. Gooderham","orcid":"https://orcid.org/0000-0001-7645-8219","observed_orcids":["https://orcid.org/0000-0001-7645-8219"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nigel J. Gooderham","raw_affiliation_strings":["Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078090457","display_name":"Timothy W. Gant","orcid":"https://orcid.org/0000-0001-9057-4937","observed_orcids":["https://orcid.org/0000-0001-9057-4937"]},"institutions":[{"id":"https://openalex.org/I348769827","display_name":"Public Health England","ror":"https://ror.org/00vbvha87","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I348769827"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Timothy W. Gant","raw_affiliation_strings":["Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Science and Innovation Campus OX11 0RQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Science and Innovation Campus OX11 0RQ, UK","institution_ids":["https://openalex.org/I348769827"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kenneth L. Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kenneth L. Clark","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075930262","display_name":"Stephen A. Hughes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen A. Hughes","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002246418","display_name":"Mark R. Edbrooke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark R. Edbrooke","raw_affiliation_strings":["GlaxoSmithKline R&D, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022140456","display_name":"Joel D. Parry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joel D. Parry","raw_affiliation_strings":["GlaxoSmithKline R&D, Ware SG12 0DP, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Ware SG12 0DP, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5026067835"],"corresponding_institution_ids":["https://openalex.org/I188950975","https://openalex.org/I348769827","https://openalex.org/I47508984"],"apc_list":{"value":3992,"currency":"USD","value_usd":3992},"apc_paid":{"value":3992,"currency":"USD","value_usd":3992},"fwci":3.5999,"has_fulltext":true,"cited_by_count":126,"citation_normalized_percentile":{"value":0.94602428,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"43","issue":"18","first_page":"8638","last_page":"8650"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.07289999723434448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9940000176429749},{"id":"https://openalex.org/keywords/gapmer","display_name":"gapmer","score":0.7379999756813049},{"id":"https://openalex.org/keywords/off-target-effects","display_name":"off-target effects","score":0.9850000143051147},{"id":"https://openalex.org/keywords/lna","display_name":"LNA","score":0.492000013589859},{"id":"https://openalex.org/keywords/phosphorothioate","display_name":"phosphorothioate","score":0.800000011920929},{"id":"https://openalex.org/keywords/bach1","display_name":"BACH1","score":0.9359999895095825},{"id":"https://openalex.org/keywords/rnase-h1","display_name":"RNase H1","score":0.8370000123977661},{"id":"https://openalex.org/keywords/mismatch","display_name":"mismatch","score":0.40400001406669617},{"id":"https://openalex.org/keywords/off-target-prediction","display_name":"off-target prediction","score":0.6110000014305115},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.656000018119812},{"id":"https://openalex.org/keywords/spliced-transcripts","display_name":"spliced transcripts","score":0.5720000267028809},{"id":"https://openalex.org/keywords/mrna-knockdown","display_name":"mRNA knockdown","score":0.4959999918937683}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7711691856384277},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.7411344051361084},{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.6592717170715332},{"id":"https://openalex.org/C10879258","wikidata":"https://www.wikidata.org/wiki/Q76826611","display_name":"RNase P","level":4,"score":0.604425847530365},{"id":"https://openalex.org/C69766542","wikidata":"https://www.wikidata.org/wiki/Q3430179","display_name":"RNase H","level":5,"score":0.5814270377159119},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5606651902198792},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.5183318853378296},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.46493834257125854},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.45404258370399475},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.4370403587818146},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3346610367298126},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3261483907699585},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.321742981672287},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2924612760543823},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.22036948800086975}],"mesh":[{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005091","descriptor_name":"Exons","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007438","descriptor_name":"Introns","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D016914","descriptor_name":"Ribonuclease H","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020137","descriptor_name":"Base Pair Mismatch","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020868","descriptor_name":"Gene Silencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055785","descriptor_name":"Gene Knockdown Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1093/nar/gkv857","doi":"https://doi.org/10.1093/nar/gkv857","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nar/gkv857","pdf_url":null,"source":{"id":"https://openalex.org/S134668137","display_name":"Nucleic Acids Research","issn_l":"0305-1048","issn":["0305-1048","1362-4954","1362-4962"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4605310","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4605310/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4605310/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Res","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:3582879","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4605310","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:26338776","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26338776","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic acids research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/nar/gkv857","doi":"https://doi.org/10.1093/nar/gkv857","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nar/gkv857","pdf_url":null,"source":{"id":"https://openalex.org/S134668137","display_name":"Nucleic Acids Research","issn_l":"0305-1048","issn":["0305-1048","1362-4954","1362-4962"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.766700029373169}],"study_designs":[],"awards":[{"id":"https://openalex.org/G166720813","display_name":null,"funder_award_id":"EP/J502017/1","funder_id":"https://openalex.org/F4320321067","funder_display_name":"Public Health England"},{"id":"https://openalex.org/G6953226623","display_name":"Industrial CASE Account - Imperial College London 2011","funder_award_id":"EP/J502017/1","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"}],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320320283","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10"},{"id":"https://openalex.org/F4320321067","display_name":"Public Health England","ror":"https://ror.org/00vbvha87"},{"id":"https://openalex.org/F4320334627","display_name":"Engineering and Physical Sciences Research Council","ror":"https://ror.org/0439y7842"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1908974948.pdf","grobid_xml":"https://content.openalex.org/works/W1908974948.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1502920935","https://openalex.org/W1564730852","https://openalex.org/W1600624961","https://openalex.org/W1961577685","https://openalex.org/W1964196894","https://openalex.org/W1988582067","https://openalex.org/W1996491588","https://openalex.org/W2006167464","https://openalex.org/W2007712749","https://openalex.org/W2022756254","https://openalex.org/W2032426626","https://openalex.org/W2038332844","https://openalex.org/W2040089348","https://openalex.org/W2052322311","https://openalex.org/W2054757478","https://openalex.org/W2055986000","https://openalex.org/W2058165751","https://openalex.org/W2059757022","https://openalex.org/W2065247620","https://openalex.org/W2073262299","https://openalex.org/W2074231493","https://openalex.org/W2081716128","https://openalex.org/W2087657020","https://openalex.org/W2088707712","https://openalex.org/W2092474773","https://openalex.org/W2096010243","https://openalex.org/W2113038023","https://openalex.org/W2113425358","https://openalex.org/W2120224302","https://openalex.org/W2122289183","https://openalex.org/W2129718981","https://openalex.org/W2130886644","https://openalex.org/W2131447660","https://openalex.org/W2132343975","https://openalex.org/W2133380348","https://openalex.org/W2136021600","https://openalex.org/W2137854030","https://openalex.org/W2143228863","https://openalex.org/W2152545090","https://openalex.org/W2157085976","https://openalex.org/W2165586566","https://openalex.org/W2167408428","https://openalex.org/W2171120202","https://openalex.org/W2171776498","https://openalex.org/W2411860414","https://openalex.org/W2491658622","https://openalex.org/W2517077698","https://openalex.org/W2597511442","https://openalex.org/W2952510860","https://openalex.org/W3088677342","https://openalex.org/W4210290733","https://openalex.org/W6660482981"],"related_works":["https://openalex.org/W2911385241","https://openalex.org/W2981833564","https://openalex.org/W2770396564","https://openalex.org/W2730536591","https://openalex.org/W2902180176","https://openalex.org/W2092474773","https://openalex.org/W2799858598","https://openalex.org/W4414606943","https://openalex.org/W6981941967","https://openalex.org/W7154631233"],"abstract_inverted_index":{"With":[0],"many":[1],"safety":[2,137],"and":[3,85,97,118,156,163],"technical":[4],"limitations":[5],"partly":[6],"mitigated":[7],"through":[8],"chemical":[9],"modifications,":[10],"antisense":[11],"oligonucleotides":[12],"(ASOs)":[13],"are":[14,53],"gaining":[15],"recognition":[16,147],"as":[17,51,174,176],"therapeutic":[18],"entities.":[19],"The":[20],"increase":[21,32],"in":[22,82,167,182],"potency":[23,129],"realized":[24],"by":[25],"'third":[26],"generation":[27],"chemistries'":[28],"may,":[29],"however,":[30],"simultaneously":[31],"affinity":[33],"to":[34,151],"unintended":[35],"targets":[36],"with":[37,90,101,126,143,190],"partial":[38],"sequence":[39],"complementarity.":[40],"However,":[41],"putative":[42,154],"hybridization-dependent":[43],"off-target":[44],"effects":[45],"(OTEs),":[46],"a":[47,91,135],"risk":[48],"historically":[49],"regarded":[50],"low,":[52],"not":[54],"being":[55],"adequately":[56],"investigated.":[57],"Here":[58],"we":[59],"show":[60,140],"an":[61],"unexpectedly":[62],"high":[63,128],"OTEs":[64],"confirmation":[65],"rate":[66],"during":[67,160],"screening":[68],"of":[69,88,94,114,130],"fully":[70],"phosphorothioated":[71],"(PS)-LNA":[72],"gapmer":[73],"ASOs":[74],"designed":[75],"against":[76,111,171],"the":[77,107,153,158,184,187],"BACH1":[78],"transcript.":[79],"We":[80,139],"demonstrate":[81],"vitro":[83],"mRNA":[84],"protein":[86],"knockdown":[87],"off-targets":[89,155],"wide":[92],"range":[93],"mismatch":[95],"(MM)":[96],"gap":[98],"patterns.":[99],"Furthermore,":[100],"RNase":[102],"H1":[103],"activity":[104],"residing":[105],"within":[106],"nucleus,":[108],"hybridization":[109],"predicted":[110],"intronic":[112],"regions":[113],"pre-mRNAs":[115],"was":[116],"tested":[117],"confirmed.":[119],"This":[120],"dramatically":[121],"increased":[122],"ASO-binding":[123],"landscape":[124],"together":[125],"relatively":[127],"such":[131],"interactions":[132],"translates":[133],"into":[134],"considerable":[136],"concern.":[138],"here":[141],"that":[142],"base":[144],"pairing-driven":[145],"target":[146],"it":[148],"is":[149],"possible":[150],"predict":[152],"address":[157],"liability":[159],"lead":[161],"design":[162],"optimization":[164],"phases.":[165],"Moreover,":[166],"silico":[168],"analysis":[169],"performed":[170],"both":[172],"primary":[173],"well":[175],"spliced":[177],"transcripts":[178],"will":[179],"be":[180],"invaluable":[181],"elucidating":[183],"mechanism":[185],"behind":[186],"hepatoxicity":[188],"observed":[189],"some":[191],"LNA-modified":[192],"gapmers.":[193]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1908974948","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
